You are here

Investigating patterns of degeneration in Alzheimer's disease

Comment

Discuss

Alzheimer’s disease is known to cause memory loss and cognitive decline, but other functions of the brain can remain intact. The reasons cells in some brain regions degenerate while others are protected is largely unknown. Now, researchers from Brigham and Women’s Hospital have found that factors encoded in the DNA of brain cells contribute to the patterns of degeneration, or vulnerability, in Alzheimer’s disease.

Alzheimer’s is characterized by plaques composed of amyloid β-protein (Aβ) and tangles composed of Tau protein; accumulation of Aβ protein leads to disruption of Tau and, eventually, neurodegeneration, which affects brain regions in a variety of ways. The front rostral portion of the brain is generally more damaged by plaque buildup while the back caudal portion is generally spared.

Though there are several mechanisms that could cause these differences, the team focused on the potential contributions of cell-autonomous factors among neuronal subtypes that could affect both the generation of and the responses to Aβ. In a novel application of human induced-pluripotent stem cell (iPSC) technology, the team generated powerful culture systems that represent different areas of the brain.

The systems were developed by taking skin cells from patients with a familial Alzheimer's disease mutation and turning these skin cells into stem cells. Stem cells can be turned into any type of cell in the body, including brain cells. In this study, the authors showed that vulnerable brain cells made more toxic Aβ protein compared to brain cells from more protected regions of the brain.

In addition, they found that cells in the protected caudal portion of the brain have a less toxic response to Aβ than their rostral counterparts. Though early-onset, familial Alzheimer's disease accounts for a small number of familial Alzheimer's cases, the study of familial Alzheimer's patients, or samples in this case, can reveal important aspects of the cell and molecular mechanisms underlying all types of Alzheimer’s. The team is currently using this information to investigate exactly why caudal neurons are protected and what differences in cell type cause neurons to be protected from Alzheimer’s.

"These findings illuminate our understanding of why some neurons are spared and why others are not spared in AD," said Christina Muratore, Ph.D., of Brigham and Women's Department of Neurology. "If we can find out more information about why these subtypes of cells are protected, we may be able to use this information to tailor therapies to protect the vulnerable cells."

The study is published in Stem Cell Reports.

Learn more:

https://bwhclinicalandresearchnews.org/2017/11/13/whats-new-in-research-november-2017/

DOI: 10.1016/j.stemcr.2017.10.015